Seroprevalencia a SARS CoV-2 en pacientes atendidos en el Hospital de Contingencia de Ayacucho, Perú. Abril 2020 – diciembre 2021
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El objetivo fue investigar la prevalencia de anticuerpos contra SARS-CoV-2 en los pacientes tratados en el Hospital de Contingencia de Ayacucho, Perú. La investigación se realizó entre abril de 2020 y diciembre de 2021 en este hospital, situado en el distrito y provincia de Huamanga, en el departamento de Ayacucho. Se utilizó un enfoque descriptivo y retrospectivo en la investigación. La muestra estuvo conformada por 11036 individuos que cumplieron con los criterios de selección estipulados. Se empleó una técnica de recolección de fuente primaria, utilizando como instrumento la ficha epidemiológica de COVID-19. Se encontró una prevalencia de infección por SARS-CoV-2 del 33.72%. En cuanto a la seroprevalencia de inmunoglobulinas, se determinó que el 6.60% correspondía a IgM, el 10.82% a IgG, y el 16.39% a la combinación de IgM e IgG. En relación con el género, la prevalencia fue del 29.88% en mujeres y del 39.19% en hombres. La mayor prevalencia por grupo de edad se registró en personas de entre 30 y 44 años, con un 29.40%. Respecto a la procedencia, los pacientes de Ayacucho presentaron una prevalencia del 32.59%, mientras que San José de Ticllas tuvo la prevalencia más baja, con un 41.51%.
The goal of this research was to measure the prevalence of antibodies against SARS-CoV-2 in patients treated at the Contingency Hospital of Ayacucho, Peru. The study was conducted between April 2020 and December 2021 at this hospital, located in the district and province of Huamanga, in the department of Ayacucho. A descriptive and retrospective approach was used in the investigation. The sample consisted of 11,036 individuals who met the stipulated selection criteria. A primary source data collection technique was employed, using the CORONAVIRUS 2019epidemiological record as the instrument. A prevalence of SARS-CoV-2 infection of 33.72% was found. Regarding the seroprevalence of immunoglobulins, it was determined that 6.60% corresponded to IgM, 10.82% to IgG, and 16.39% to a combination of IgM and IgG. In terms of gender, the prevalence was 29.88% in women and 39.19% in men. The highest prevalence by age group was recorded in individuals aged 30 to 44 years, with 29.40%. Regarding origin, patients from Ayacucho showed a prevalence of 32.59%, while San José de Ticllas had the lowest prevalence, with 41.51%.
The goal of this research was to measure the prevalence of antibodies against SARS-CoV-2 in patients treated at the Contingency Hospital of Ayacucho, Peru. The study was conducted between April 2020 and December 2021 at this hospital, located in the district and province of Huamanga, in the department of Ayacucho. A descriptive and retrospective approach was used in the investigation. The sample consisted of 11,036 individuals who met the stipulated selection criteria. A primary source data collection technique was employed, using the CORONAVIRUS 2019epidemiological record as the instrument. A prevalence of SARS-CoV-2 infection of 33.72% was found. Regarding the seroprevalence of immunoglobulins, it was determined that 6.60% corresponded to IgM, 10.82% to IgG, and 16.39% to a combination of IgM and IgG. In terms of gender, the prevalence was 29.88% in women and 39.19% in men. The highest prevalence by age group was recorded in individuals aged 30 to 44 years, with 29.40%. Regarding origin, patients from Ayacucho showed a prevalence of 32.59%, while San José de Ticllas had the lowest prevalence, with 41.51%.
Description
Keywords
Coronavirus 2019, coronavirus causante de COVID-19, anticuerpos y Frecuencia